©The Author(s) 2026.
World J Gastroenterol. Jan 21, 2026; 32(3): 113187
Published online Jan 21, 2026. doi: 10.3748/wjg.v32.i3.113187
Published online Jan 21, 2026. doi: 10.3748/wjg.v32.i3.113187
Table 2 Uni-/multi-variable analysis with several predictors in hepatocellular carcinoma patients
| Variable | Univariate analysis | Multivariable analysis | ||||
| HR | P > |z| | 95%CI | HR | P > |z| | 95%CI | |
| Age (years) | ||||||
| ≤ 60 vs > 60 | 1.482 | 0.502 | 0.512-3.661 | |||
| Gender | ||||||
| Male vs female | 0.931 | 0.828 | 0.411-2.183 | |||
| Grade of differentiation | ||||||
| Low vs high | 1.316 | 0.515 | 0.571-3.545 | |||
| Tumor number | ||||||
| Single vs multiple | 1.105 | 0.779 | 0.428-2.806 | |||
| Liver cirrhosis | ||||||
| Absent vs present | 2.805 | 0.018a | 1.161-7.531 | 2.401 | 0.013a | 1.038-5.187 |
| Hepatitis B virus | ||||||
| Absent vs present | 0.422 | 0.015a | 0.156-0.805 | 0.361 | 0.008a | 0.152-0.796 |
| Periportal embolus | ||||||
| Absent vs present | 5.589 | 0.126 | 0.791-41.033 | |||
| AFP (μg/L) | ||||||
| < 400 vs ≥ 400 | 0.788 | 0.402 | 0.516-1.328 | |||
| TNM staging | ||||||
| I-II vs III-IV | 0.221 | 0.187 | 0.134-1.485 | |||
| CD24 expression | ||||||
| Low vs high | 12.586 | < 0.001a | 3.531-52.023 | 5.58 | < 0.001a | 2.421-14.928 |
- Citation: Cai Y, Liu LY, Xia XX, Tang H, Xu M, Sai WL, Yao DF, Yao M. Stemness CD24 activation promotes hepatocellular carcinoma progression via an immune escape mechanism. World J Gastroenterol 2026; 32(3): 113187
- URL: https://www.wjgnet.com/1007-9327/full/v32/i3/113187.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i3.113187